Cashu
PAVmed Collaborates with Duke University to Enhance Esophageal Dysplasia Diagnosis Technology
5 days ago
Stocks
Health Care
pavm
PAVmed
NASDAQ: PAVM
+0.01 (+1.24%)
0.4478
USD
At close at Sep 03, 18:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
7.79M
Dividend Yield
0.00%
P/E Ratio
0.11
EPS
2.62
Revenue
3.00M
Avg. Volume
208.09K
About
What does PAVM do?
PAVmed, a New York-based medical device company, specializes in medical technologies and employs 107 staff. Its subsidiaries include Lucid Diagnostics, offering cancer detection products, and Veris Health, focused on personalized cancer care.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.